TYL (TYL)

$14.5B
Market Cap
46.8
P/E Ratio
0.93
Beta
Dividend Yield
Piotroski 7/9Altman Z 5.7 SafeBeneish M -2.71 Clean

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 5.7 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics display a robust balance sheet and operational integrity, evidenced by a high Piotroski F-Score of 7/9 and a negative Beneish M-Score of -2.71 that strongly suggests earnings quality is not being manipulated. Return on Equity decomposes into three distinct drivers: healthy gross margins at 46.5% supported by net margins near 13.5%, moderate asset turnover of 0.41x, and conservative leverage with an equity multiplier of only 1.52x, indicating the firm relies more on operational efficiency than financial engineering to generate returns. While the ROIC stands at a modest 8.0% relative to typical high-growth peers, the combination of strong profitability metrics and low debt suggests stable capital generation rather than aggressive expansion risk.

Valuation metrics present a significant divergence between historical norms and intrinsic value models. The current price-to-earnings ratio of 46.8x implies that the market is pricing in substantial future growth acceleration far beyond the reported year-over-year revenue increase of 9.1%. This premium valuation contrasts sharply with a Discounted Cash Flow analysis yielding a fair value estimate of $438, suggesting the current market price may be detached from cash flow fundamentals unless implied growth rates exceed conservative assumptions. The wide gap between the multiple and the DCF-derived floor indicates that any shortfall in future execution would likely result in immediate re-rating pressure on the stock price.

Risk assessment is complicated by conflicting signals regarding insider sentiment versus fundamental strength. Despite the high quality scores indicating sound financial management, there has been $1,964,566 of net insider selling over the last 90 days, which often precedes downside volatility or suggests insiders are taking profits at elevated levels. This divergence between strong operational metrics and active insider distribution warrants caution; while the balance sheet remains solid with low leverage, the combination of expensive valuation and negative insider flow creates a scenario where downside protection is thin if growth expectations fail to materialize as priced in by the market.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$578$429$340
3%$675$477$367
4%$819$541$402

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $477 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
5.7
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.71
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

46.5%
Gross Margin
13.5%
Net Margin
8.0%
ROIC
+9.1%
Revenue Growth (YoY)
+20.0%
Earnings Growth (YoY)
620.8M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

13.5%
Net Profit Margin
NI ÷ Revenue
×
0.41x
Asset Turnover
Revenue ÷ Assets
×
1.52x
Equity Multiplier
Assets ÷ Equity
=
8.5%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

0.52x
Debt / Equity
1.05x
Current Ratio
79.1x
Interest Coverage
4.59%
FCF Yield
543.2M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$2M
Net Selling
2
Buy Transactions
3
Sale Transactions
2026-03-12CARTER GLENN A.Sold 4/8 qtrsSale$567,003
2026-03-12CARTER GLENN A.Sold 4/8 qtrsGrant$550,950
2026-03-05PUCKETT JEFFREY DAVIDSold 3/8 qtrsSale$2M
2026-03-02POPE DANIEL MSold 4/8 qtrsSale$177,700
2026-02-27PUCKETT JEFFREY DAVIDSold 3/8 qtrsOther9,102 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $2.56
Act: $2.78
+8.7%
Q3
✓ Beat
Est: $2.78
Act: $2.91
+4.8%
Q2
✓ Beat
Est: $2.86
Act: $2.97
+3.9%
Q1
✗ Miss
Est: $2.73
Act: $2.64
-3.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

23.8
Forward P/E
PEG Ratio
3.94
Price/Book
647788
Avg Volume
$621.34
52W High
$283.72
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.0B
Tracked Passive Exposure
8
ETFs Holding TYL
0.04%
Avg Weight in ETFs
$4.9T
Total ETF AUM

When investors buy or sell ETFs like MOAT or XSW, the fund manager is mechanically forced to buy or sell TYL shares regardless of TYL's individual fundamentals. We estimate $2.0B of passive capital is structurally linked to TYL through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in TYL to visualize passive redemption contagion across ETFs and collateral stocks.

TYL Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
TYLEpicenterVOOETFIVVETFSPYETFSTXLow RiskVRTLow RiskHIILow RiskABNBLow RiskELMed Risk
TYL Price Drop (%)0

If TYL (TYL) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Seagate Technology Holdings plc (STX) as the most exposed collateral stock, sharing 1 ETFs with TYL. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 29 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

TYL Ownership Dynamics

Ticker
TYL

Float lock-up computed from 32 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

TYL Capital Efficiency

How efficiently does TYL convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$621M
EBITDA
$543M
FCF Conversion
114%
Reinvestment Rate
-14%
114% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

TYL converts 114% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1456,422$298.59$16.8M
2026-05-1356,431$309.65$17.5M
2026-05-052$327.25$654.5
2026-05-014$341.14$1,364.56
2026-04-221$341.46$341.46
2026-04-211$345.93$345.93
2026-04-20146$342.61$50,021.06
2026-04-16974$337.61$328,832.14
2026-04-0725$337.20$8,430
2026-04-06971$338.03$328,227.13
2026-03-254$338.27$1,353.08
2026-03-237$350.20$2,451.4
2026-03-0423,044$367.22$8.5M
2026-03-0210$354.69$3,546.9
2026-02-2749,965$353.11$17.6M
2026-02-033$362.88$1,088.64
2026-02-021,923$369.40$710,356.2
2026-01-1325$446.46$11,161.5
2026-01-09298$453.40$135,113.2
2025-12-29439$461.06$202,405.34
2025-12-23809$464.97$376,160.73
2025-12-2210,934$457.90$5.0M
2025-12-16671$447.00$299,937
2025-12-0825$469.33$11,733.25
2025-12-044,839$461.84$2.2M
2025-12-01355$469.62$166,715.1
2025-11-2843$465.96$20,036.28
2025-11-071,098$465.01$510,580.98
2025-11-0332$476.26$15,240.32
2025-10-30106$478.00$50,668

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare TYL to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.